Carbometrics is an innovative startup that is changing the landscape of diabetes treatment by using cutting-edge chemistry to design and develop highly accurate and robust glucose sensing systems. Through their specialized carbohydrate-binding molecule (GBM) technology, the Bristol-based startup aims to create a market-leading Continuous Glucose Monitoring (CGM) solution that can enable people with diabetes to live more normal and longer lives.
How Carbometrics is Revolutionizing Diabetes Treatment
Carbometrics is an exciting new startup that aims to revolutionize diabetes treatment by creating a market-leading glucose sensing platform that can help people with diabetes manage their condition more effectively. Using their specialized GBM technology, the team at Carbometrics is able to design, synthesize, and derivatize highly selective and robust carbohydrate-binding molecules that can accurately monitor glucose levels in real-time.
Unlike traditional CGM systems, which can be unreliable and require frequent calibration, Carbometrics’ platform is designed to be highly robust and accurate, enabling people with diabetes to achieve better glucose control and reduce the risk of complications such as heart disease, kidney failure, and nerve damage.
The Science Behind Carbometrics’ GBM Technology
Carbometrics’ innovative glucose sensing platform is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the University of Bristol. Using their extensive knowledge of carbohydrate chemistry and chemical biology, the team has developed a unique GBM technology that can selectively bind to glucose molecules with high affinity and specificity.
By combining this technology with state-of-the-art signal amplification and data analysis techniques, Carbometrics is able to create a highly accurate and reliable glucose sensing platform that can provide real-time glucose monitoring without the need for frequent calibration or invasive procedures.
Carbometrics’ Success Story and Future Plans
Carbometrics was founded by a team of experienced chemists and entrepreneurs who previously sold their first company, Ziylo, to Novo Nordisk. Following this acquisition, Novo Nordisk is now using the same platform to develop smart insulins that can respond to changes in blood glucose levels more effectively.
However, Carbometrics retained the GBM technology and has now set out to exploit it to create a market-leading CGM solution that can have a significant impact on the lives of people with diabetes. With a team of world-class scientists and engineers, Carbometrics is well-positioned to achieve this goal and become a major player in the diabetes care market.
Conclusion
Carbometrics is an exciting startup that has the potential to revolutionize the way diabetes is treated and managed. By leveraging their specialized GBM technology, Carbometrics aims to create a highly accurate and reliable CGM solution that can enable people with diabetes to live more normal and longer lives. With a strong scientific foundation and a talented team of experts, Carbometrics is well-positioned to make a significant impact on the lives of people with diabetes in the years to come.
Website: https://www.carbometrics.com/
Twitter: https://twitter.com/carbometrics?lang=en
LinkedIn: https://www.linkedin.com/company/carbometrics
Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on UKT.news. Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.
